Abstract
This study aims to understand the holistic disease burden and treatment experiences for Duchenne muscular dystrophy (DMD) patients despite the use of pharmacotherapy, with a focus on corticosteroid (CS) use.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
